000710 贝瑞基因
已收盘 02-13 15:00:00
资讯
新帖
简况
股市必读：贝瑞基因（000710）2月4日董秘有最新回复
证券之星 · 02-05
股市必读：贝瑞基因（000710）2月4日董秘有最新回复
股市必读：贝瑞基因（000710）1月30日董秘有最新回复
证券之星 · 02-02
股市必读：贝瑞基因（000710）1月30日董秘有最新回复
贝瑞基因：公司暂无此类明确计划
证券之星 · 01-30
贝瑞基因：公司暂无此类明确计划
贝瑞基因（000710）披露2025年度业绩预告，1月29日股价上涨0.64%
证券之星 · 01-29
贝瑞基因（000710）披露2025年度业绩预告，1月29日股价上涨0.64%
1月26日贝瑞基因现1笔折价10.74%的大宗交易 合计成交3229.82万元
证券之星 · 01-26
1月26日贝瑞基因现1笔折价10.74%的大宗交易 合计成交3229.82万元
股市必读：贝瑞基因（000710）1月16日收盘跌5.41%，主力净流出5645.53万元
证券之星 · 01-19
股市必读：贝瑞基因（000710）1月16日收盘跌5.41%，主力净流出5645.53万元
股市必读：贝瑞基因（000710）1月15日收盘跌停，主力净流出3526.73万元
证券之星 · 01-16
股市必读：贝瑞基因（000710）1月15日收盘跌停，主力净流出3526.73万元
贝瑞基因（000710）披露关于持股5%以上股东所持部分股份被司法强制执行实施结果的公告，01月14日股价上涨3.81%
证券之星 · 01-14
贝瑞基因（000710）披露关于持股5%以上股东所持部分股份被司法强制执行实施结果的公告，01月14日股价上涨3.81%
贝瑞基因：1月12日高管高扬减持股份合计200股
中金财经 · 01-13
贝瑞基因：1月12日高管高扬减持股份合计200股
贝瑞基因：1月9日高管高扬减持股份合计7300股
证券之星 · 01-12
贝瑞基因：1月9日高管高扬减持股份合计7300股
贝瑞基因：1月8日高管高扬减持股份合计24.4万股
证券之星 · 01-09
贝瑞基因：1月8日高管高扬减持股份合计24.4万股
贝瑞基因：1月6日高管高扬减持股份合计140.37万股
证券之星 · 01-07
贝瑞基因：1月6日高管高扬减持股份合计140.37万股
贝瑞基因（000710）公司公告披露2025年第一次临时股东大会决议，12月26日股价下跌1.39%
证券之星 · 2025-12-26
贝瑞基因（000710）公司公告披露2025年第一次临时股东大会决议，12月26日股价下跌1.39%
贝瑞基因：12月2日高管高扬减持股份合计92.67万股
证券之星 · 2025-12-03
贝瑞基因：12月2日高管高扬减持股份合计92.67万股
贝瑞基因：控股股东高扬354万股将被强制变现
财中社 · 2025-11-19
贝瑞基因：控股股东高扬354万股将被强制变现
贝瑞基因（000710）披露为全资子公司借款提供反担保进展，11月11日股价下跌0.95%
证券之星 · 2025-11-11
贝瑞基因（000710）披露为全资子公司借款提供反担保进展，11月11日股价下跌0.95%
异动快报：贝瑞基因（000710）11月3日9点44分触及涨停板
证券之星 · 2025-11-03
异动快报：贝瑞基因（000710）11月3日9点44分触及涨停板
股市必读：贝瑞基因三季报 - 第三季度单季净利润同比下降2355.45%
证券之星 · 2025-11-03
股市必读：贝瑞基因三季报 - 第三季度单季净利润同比下降2355.45%
贝瑞基因（000710）2025年三季报简析：净利润同比下降606.13%，公司应收账款体量较大
证券之星 · 2025-11-01
贝瑞基因（000710）2025年三季报简析：净利润同比下降606.13%，公司应收账款体量较大
贝瑞基因最新公告：全球首款获准应用于临床的三代基因测序平台Sequel®IICNDx获得医疗器械注册证
证券之星 · 2025-10-31
贝瑞基因最新公告：全球首款获准应用于临床的三代基因测序平台Sequel®IICNDx获得医疗器械注册证
暂无数据
公司概况
公司名称：
成都市贝瑞和康基因技术股份有限公司
所属行业：
专业技术服务业
上市日期：
1997-04-22
主营业务：
成都市贝瑞和康基因技术股份有限公司的主营业务是以高通量测序技术、三代HiFi测序技术为基础的基因检测服务和基因检测相关的设备、试剂、软件销售。公司的主要产品是覆盖出生缺陷三级预防的生育健康基因检测及覆盖儿童及成人的遗传病基因检测服务。
发行价格：
5.10
{"stockData":{"symbol":"000710","market":"SZ","secType":"STK","nameCN":"贝瑞基因","latestPrice":12.3,"timestamp":1770966234000,"preClose":12.35,"halted":0,"volume":4839645,"delay":0,"changeRate":-0.004,"floatShares":330000000,"shares":354000000,"eps":-0.7224,"marketStatus":"已收盘","change":-0.05,"latestTime":"02-13 15:00:00","open":12.4,"high":12.55,"low":12.29,"amount":60016600,"amplitude":0.0211,"askPrice":12.31,"askSize":3,"bidPrice":12.3,"bidSize":139,"shortable":0,"etf":0,"ttmEps":-0.7224,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":12.35,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":13.59,"lowLimit":11.12,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":353521465,"isCdr":false,"pbRate":2.7,"roa":"--","roe":"--","epsLYR":-0.5443,"committee":0.115516,"marketValue":4348000000,"turnoverRate":0.0147,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-02-24。","floatMarketCap":4053000000},"requestUrl":"/m/hq/s/000710/tweets","defaultTab":"tweets","newsList":[{"id":"2609639495","title":"股市必读：贝瑞基因（000710）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609639495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609639495?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:55","pubTimestamp":1770227714,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，贝瑞基因报收于12.28元，上涨0.57%，换手率2.34%，成交量7.7万手，成交额9372.63万元。董秘最新回复投资者： 尊敬的董秘你好！关于AI赋能的商业模式创新，AI的引入可能催生新的服务模式。公司在AI+基因测序领域已有哪些布局和落地成果？当日关注点来自交易信息汇总：2月4日主力资金净流出495.9万元，散户资金净流入584.55万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000710","BK0221","BK0028","BK0102","BK0139","BK0081","BK0042"],"gpt_icon":0},{"id":"2608886399","title":"股市必读：贝瑞基因（000710）1月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2608886399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608886399?lang=zh_cn&edition=full","pubTime":"2026-02-02 02:07","pubTimestamp":1769969233,"startTime":"0","endTime":"0","summary":"截至2026年1月30日收盘，贝瑞基因报收于12.05元，下跌3.91%，换手率4.36%，成交量14.37万手，成交额1.74亿元。交易信息汇总1月30日主力资金净流出1964.56万元；游资资金净流出1686.42万元；散户资金净流入3650.98万元。公司公告汇总成都市贝瑞和康基因技术股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为-25,000万元至-17,000万元，扣除非经常性损益后的净利润为-24,500万元至-16,500万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0081","BK0139","BK0042","BK0102","BK0086","BK0221","000710","BK0028"],"gpt_icon":0},{"id":"2607604801","title":"贝瑞基因：公司暂无此类明确计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2607604801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607604801?lang=zh_cn&edition=full","pubTime":"2026-01-30 20:53","pubTimestamp":1769777603,"startTime":"0","endTime":"0","summary":"证券之星消息，贝瑞基因(000710)01月30日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘你好！美国知名投资者“木头姐”大举投资基因公司TEM，我看了下此公司和公司业务高度契合，请问公司未来有没有想邀请像“木头姐”一样的投资者及机构来战略投资公司，把公司做大做强。贝瑞基因回复：投资人您好！公司暂无此类明确计划，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000043738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0221","BK0042","BK0086","BK0102","000710","BK0081","BK0028"],"gpt_icon":0},{"id":"2607903627","title":"贝瑞基因（000710）披露2025年度业绩预告，1月29日股价上涨0.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607903627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607903627?lang=zh_cn&edition=full","pubTime":"2026-01-29 23:03","pubTimestamp":1769698996,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，贝瑞基因报收于12.54元，较前一交易日上涨0.64%，最新总市值为44.33亿元。该股当日开盘12.38元，最高12.88元，最低12.12元，成交额达2.09亿元，换手率为5.04%。近日，成都市贝瑞和康基因技术股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为-25,000万元至-17,000万元，扣除非经常性损益后的净利润为-24,500万元至-16,500万元。本次业绩预告未经审计，最终数据以2025年年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0081","BK0042","BK0139","BK0221","BK0102","BK0028","BK0086"],"gpt_icon":0},{"id":"2606160702","title":"1月26日贝瑞基因现1笔折价10.74%的大宗交易 合计成交3229.82万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606160702","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606160702?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:17","pubTimestamp":1769422646,"startTime":"0","endTime":"0","summary":"证券之星消息，1月26日贝瑞基因发生大宗交易，交易数据如下：大宗交易成交价格11.88元，相对当日收盘价折价10.74%，成交271.87万股，成交金额3229.82万元，买方营业部为国泰海通证券股份有限公司瑞安莘阳大道证券营业部，卖方营业部为江海证券有限公司上海万航渡路证券营业部。近三个月该股共发生1笔大宗交易，合计成交2.72万手，折价成交1笔。截至2026年1月26日收盘，贝瑞基因报收于13.31元，上涨0.91%，换手率7.15%，成交量23.55万手，成交额3.13亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600024741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0139","BK0221","BK0042","BK0081","BK0028","BK0102","BK0086"],"gpt_icon":0},{"id":"2604797947","title":"股市必读：贝瑞基因（000710）1月16日收盘跌5.41%，主力净流出5645.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604797947","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604797947?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:04","pubTimestamp":1768755855,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，贝瑞基因报收于12.77元，下跌5.41%，换手率11.14%，成交量36.71万手，成交额4.78亿元。当日关注点来自：贝瑞基因1月16日收盘报12.77元，跌5.41%，当日成交3671.03万元，主力资金净流出6391.61万元，散户资金净流入7251.05万元。该股已连续2日下跌，近5个交易日中有2日跌幅超5%。前10个交易日主力资金累计净流入8163.22万元，同期股价累计上涨12.94%。资金流向1月16日主力资金净流出6391.61万元，游资资金净流出859.44万元，散户资金净流入7251.05万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0042","BK0102","BK0081","BK0086","BK0221","BK0028","000710"],"gpt_icon":0},{"id":"2603982960","title":"股市必读：贝瑞基因（000710）1月15日收盘跌停，主力净流出3526.73万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603982960?lang=zh_cn&edition=full","pubTime":"2026-01-16 00:59","pubTimestamp":1768496347,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，贝瑞基因报收于13.5元，下跌10.0%，跌停，换手率13.88%，成交量45.73万手，成交额6.33亿元。交易信息汇总贝瑞基因1月15日收盘报13.5元，跌停，当日成交4572.87万元。前10个交易日主力资金累计净流入1.41亿元，股价累计上涨20.69%。资金流向1月15日主力资金净流出5645.53万元，游资资金净流入1346.96万元，散户资金净流入4298.58万元。本次强制执行完成后，高扬先生持股比例由7.0486%降至6.0486%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600000496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","000710","BK0139","BK0221","BK0028","BK0081","BK0102"],"gpt_icon":0},{"id":"2603614489","title":"贝瑞基因（000710）披露关于持股5%以上股东所持部分股份被司法强制执行实施结果的公告，01月14日股价上涨3.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603614489","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603614489?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:17","pubTimestamp":1768400234,"startTime":"0","endTime":"0","summary":"截至2026年1月14日收盘，贝瑞基因报收于15.0元，较前一交易日上涨3.81%，最新总市值为53.03亿元。该股当日开盘14.57元，最高15.63元，最低14.48元，成交额达14.49亿元，换手率为29.04%。公司近日发布公告称，控股股东高扬先生因在国信证券的股票质押回购业务发生违约，其所持3,535,213股公司股份被成渝金融法院裁定通过集中竞价方式强制执行，占公司总股本0.999%。本次强制执行完成后，高扬先生持股比例由7.0486%降至6.0486%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400041229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0102","BK0139","BK0221","000710","BK0042","BK0028","BK0081"],"gpt_icon":0},{"id":"2603687049","title":"贝瑞基因：1月12日高管高扬减持股份合计200股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603687049","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603687049?lang=zh_cn&edition=full","pubTime":"2026-01-13 22:01","pubTimestamp":1768312887,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月13日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因(000710)最新董监高及相关人员股份变动情况：2026年1月12日公司董事,高管高扬共减持公司股份200.0股，占公司总股本为0.0001%。变动期间公司股价上涨3.79%，1月12日当日收盘报13.14元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下： 贝瑞基因的高管列表及最新持股情况如下： 该股最近90天内无机构评级。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/13/20260113532956.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/13/20260113532956.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260113/31939048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0139","BK0221","000710","BK0028","BK0081","BK0086","BK0102","BK0042"],"gpt_icon":0},{"id":"2602697510","title":"贝瑞基因：1月9日高管高扬减持股份合计7300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602697510","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602697510?lang=zh_cn&edition=full","pubTime":"2026-01-12 21:01","pubTimestamp":1768222895,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月12日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年1月9日公司董事,高管高扬共减持公司股份7300.0股，占公司总股本为0.0021%。变动期间公司股价上涨3.6%，1月9日当日收盘报12.66元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200035045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0139","BK0081","000710","BK0086","BK0221","BK0028","BK0042","BK0102"],"gpt_icon":0},{"id":"2602664379","title":"贝瑞基因：1月8日高管高扬减持股份合计24.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602664379","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602664379?lang=zh_cn&edition=full","pubTime":"2026-01-09 21:35","pubTimestamp":1767965727,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月9日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年1月8日公司董事,高管高扬共减持公司股份24.4万股，占公司总股本为0.069%。变动期间公司股价上涨4.44%，1月8日当日收盘报12.22元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010900039626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0221","BK0042","BK0086","BK0081","BK0028","BK0139","BK0102"],"gpt_icon":0},{"id":"2601803422","title":"贝瑞基因：1月6日高管高扬减持股份合计140.37万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601803422","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601803422?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:01","pubTimestamp":1767790904,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月7日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2026年1月6日公司董事,高管高扬共减持公司股份140.37万股，占公司总股本为0.3971%。变动期间公司股价下跌0.83%，1月6日当日收盘报11.98元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700037256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0221","BK0081","BK0139","BK0042","BK0028","000710","BK0086"],"gpt_icon":0},{"id":"2594129457","title":"贝瑞基因（000710）公司公告披露2025年第一次临时股东大会决议，12月26日股价下跌1.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594129457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594129457?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:28","pubTimestamp":1766759297,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，贝瑞基因报收于11.35元，较前一交易日下跌1.39%，最新总市值为40.12亿元。该股当日开盘11.47元，最高11.55元，最低11.26元，成交额达7262.74万元，换手率为1.93%。近日，成都市贝瑞和康基因技术股份有限公司发布2025年第一次临时股东大会决议公告。公告显示，公司于2025年12月26日召开2025年第一次临时股东大会，审议通过了《关于修订〈公司章程〉的议案》《股东会议事规则》《董事会议事规则》等九项提案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0086","BK0139","BK0221","BK0081","BK0102","BK0028","000710"],"gpt_icon":0},{"id":"2588594049","title":"贝瑞基因：12月2日高管高扬减持股份合计92.67万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588594049","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588594049?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:01","pubTimestamp":1764766906,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月3日市场公开信息、上市公司公告及交易所披露数据整理，贝瑞基因（000710）最新董监高及相关人员股份变动情况：2025年12月2日公司董事,高管高扬共减持公司股份92.67万股，占公司总股本为0.2621%。变动期间公司股价下跌1.64%，12月2日当日收盘报11.96元。贝瑞基因近半年内的董监高及核心技术人员增减持详情如下：贝瑞基因的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0081","BK0086","BK0139","000710","BK0102","BK0221","BK0042"],"gpt_icon":0},{"id":"2584794135","title":"贝瑞基因：控股股东高扬354万股将被强制变现","url":"https://stock-news.laohu8.com/highlight/detail?id=2584794135","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584794135?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:50","pubTimestamp":1763556600,"startTime":"0","endTime":"0","summary":"贝瑞基因发布公告，高扬因在国信证券开展的股票质押回购业务发生违约，成渝金融法院裁定强制变现其持有的354万股“贝瑞基因”股票，占公司总股本比例0.999%。 本次被执行股份的来源为高扬在公司进行重大资产重组时以持有的贝瑞和康股权认购获得的新增股份。被执行股份的交易将于2025年12月1日至2026年2月10日进行，交易价格将根据市场情况确定。 2025年前三季度，贝瑞基因实现收入6.86亿元，归母净利润-5256万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-19/doc-infxxwtw3039155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000710","BK0102","BK0139","BK0221","BK0028","BK0081","BK0086","BK0042"],"gpt_icon":0},{"id":"2582620723","title":"贝瑞基因（000710）披露为全资子公司借款提供反担保进展，11月11日股价下跌0.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582620723","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582620723?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:22","pubTimestamp":1762870944,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，贝瑞基因报收于13.53元，较前一交易日下跌0.95%，最新总市值为47.83亿元。公司董事会认为该反担保风险可控，不存在损害公司及股东利益的情形。截至公告日，公司及控股子公司对外担保总额为30,700万元，占最近一期经审计净资产的18.28%，无逾期担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040856.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710","BK0139","BK0221","BK0042","BK0081","BK0028","BK0102","BK0086"],"gpt_icon":0},{"id":"2580255774","title":"异动快报：贝瑞基因（000710）11月3日9点44分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580255774?lang=zh_cn&edition=full","pubTime":"2025-11-03 09:45","pubTimestamp":1762134324,"startTime":"0","endTime":"0","summary":"证券之星11月3日盘中消息，9点44分贝瑞基因触及涨停板。目前价格14.4，上涨10.01%。其所属行业医疗服务目前下跌。领涨股为百诚医药。该股为DeepSeek概念股，AI 医疗，人工智能概念热股，当日DeepSeek概念股概念上涨0.91%，AI 医疗概念上涨0.53%，人工智能概念上涨0.4%。10月31日的资金流向数据方面，主力资金净流出707.64万元，占总成交额4.08%，游资资金净流出884.27万元，占总成交额5.1%，散户资金净流入1591.91万元，占总成交额9.19%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300004949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0081","BK0221","000710","BK0139","BK0028","BK0086","BK0102"],"gpt_icon":0},{"id":"2580002239","title":"股市必读：贝瑞基因三季报 - 第三季度单季净利润同比下降2355.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580002239","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580002239?lang=zh_cn&edition=full","pubTime":"2025-11-03 05:46","pubTimestamp":1762119976,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动截至2025年9月30日，贝瑞基因股东户数为6.47万户，较6月30日减少3472.0户，减幅为5.09%。业绩披露要点财务报告贝瑞基因2025年三季报显示，前三季度主营收入6.86亿元，同比下降16.65%；归母净利润-5256.37万元，同比下降606.13%；扣非净利润-5379.14万元，同比下降519.85%。2025年第三季度单季度主营收入2.38亿元，同比下降12.06%；单季度归母净利润-2532.12万元，同比下降2355.45%；单季度扣非净利润-2520.19万元，同比下降858.59%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300001224.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2580412210","title":"贝瑞基因（000710）2025年三季报简析：净利润同比下降606.13%，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2580412210","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580412210?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:36","pubTimestamp":1761950170,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期贝瑞基因发布2025年三季报。截至本报告期末，公司营业总收入6.86亿元，同比下降16.65%，归母净利润-5256.37万元，同比下降606.13%。本报告期贝瑞基因公司应收账款体量较大，当期应收账款占最新年报营业总收入比达58.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000710"],"gpt_icon":0},{"id":"2579345493","title":"贝瑞基因最新公告：全球首款获准应用于临床的三代基因测序平台Sequel®IICNDx获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2579345493","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579345493?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:53","pubTimestamp":1761904397,"startTime":"0","endTime":"0","summary":"贝瑞基因(000710.SZ)公告称，全资子公司杭州贝瑞和康基因诊断技术有限公司的三代基因测序仪SequelIICNDx近日获得国家药品监督管理局颁发的医疗器械注册证。三代基因测序仪Sequel II CNDx ，是全球首款获准应用于临床的三代基因测序平台。截至目前，贝瑞基因已完全实现三代测序配套检测试剂的自主生产和智能化解读报告系统的本地部署交付。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100038263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0102","BK0221","BK1100","BK0086","09997","BK1574","BK1222","BK0139","000710","BK1583","159883","BK0042","BK0081","09996","BK0028"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771326367358,"stockEarnings":[{"period":"1week","weight":-0.0261},{"period":"1month","weight":-0.18},{"period":"3month","weight":-0.1087},{"period":"6month","weight":-0.15},{"period":"1year","weight":0.1626},{"period":"ytd","weight":0.0895}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"成都市贝瑞和康基因技术股份有限公司","boardCode":"AI0074","boardName":"专业技术服务业","stockholders":"64711人(较上一季度减少5.09%)","perCapita":"5092股","listingDate":"1997-04-22","address":"四川省成都市龙泉驿区经济技术开发区(龙泉驿区)成都汽车城大道333号","registeredCapital":"35352万元","survey":" 成都市贝瑞和康基因技术股份有限公司的主营业务是以高通量测序技术、三代HiFi测序技术为基础的基因检测服务和基因检测相关的设备、试剂、软件销售。公司的主要产品是覆盖出生缺陷三级预防的生育健康基因检测及覆盖儿童及成人的遗传病基因检测服务。","listedPrice":5.1},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"贝瑞基因,000710,贝瑞基因股票,贝瑞基因股票老虎,贝瑞基因股票老虎国际,贝瑞基因行情,贝瑞基因股票行情,贝瑞基因股价,贝瑞基因股市,贝瑞基因股票价格,贝瑞基因股票交易,贝瑞基因股票购买,贝瑞基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"贝瑞基因(000710)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供贝瑞基因(000710)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}